Related Experiment Video
Updated: Sep 29, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Cross-Talk between p53 and Wnt Signaling in Cancer
Qiyun Xiao1, Johannes Werner2, Nachiyappan Venkatachalam1
1Department of Medicine II, Mannheim University Hospital, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.
Abstract:
Targeting cancer hallmarks is a cardinal strategy to improve antineoplastic treatment. However, cross-talk between signaling pathways and key oncogenic processes frequently convey resistance to targeted therapies. The p53 and Wnt pathway play vital roles for the biology of many tumors, as they are critically involved in cancer onset and progression. Over recent decades, a high level of interaction between the two pathways has been revealed. Here, we provide a comprehensive overview of molecular interactions between the p53 and Wnt pathway discovered in cancer, including complex feedback loops and reciprocal transactivation. The mutational landscape of genes associated with p53 and Wnt signaling is described, including mutual exclusive and co-occurring genetic alterations. Finally, we summarize the functional consequences of this cross-talk for cancer phenotypes, such as invasiveness, metastasis or drug resistance, and discuss potential strategies to pharmacologically target the p53-Wnt interaction.
Insights
The p53 and Wnt pathways interact in cancer, influencing tumor growth and resistance to therapy. Understanding these interactions is key to developing new cancer treatments targeting this cross-talk.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Targeting cancer hallmarks is crucial for antineoplastic treatment.
- Pathway cross-talk often leads to resistance against targeted therapies.
- The p53 and Wnt pathways are vital in tumor onset and progression.
Purpose of the Study:
- To provide a comprehensive overview of molecular interactions between the p53 and Wnt pathways in cancer.
- To describe the mutational landscape of genes in p53 and Wnt signaling.
- To discuss the functional consequences and therapeutic targeting of p53-Wnt cross-talk.
Main Methods:
- Literature review of molecular interactions.
- Analysis of genetic alterations in p53 and Wnt pathways.
- Summary of functional consequences and therapeutic strategies.
Main Results:
- Detailed description of molecular interactions, including feedback loops and reciprocal transactivation.
- Characterization of mutual exclusive and co-occurring genetic alterations.
- Identification of functional consequences like invasiveness, metastasis, and drug resistance.
Conclusions:
- The cross-talk between p53 and Wnt pathways significantly impacts cancer phenotypes.
- Targeting the p53-Wnt interaction presents potential therapeutic strategies for cancer treatment.
Related Concept Videos
Canonical Wnt Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway

